Flagship Pioneering Fund Vii General Partner Llc - Net Worth and Insider Trading

Flagship Pioneering Fund Vii General Partner Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Flagship Pioneering Fund Vii General Partner Llc owns 3 companies in total, including Evelo Biosciences Inc (EVLO) , Seres Therapeutics Inc (MCRB) , and Omega Therapeutics Inc (OMGAQ) .

Click here to see the complete history of Flagship Pioneering Fund Vii General Partner Llc’s form 4 insider trades.

Insider Ownership Summary of Flagship Pioneering Fund Vii General Partner Llc

Ticker	Company	Transaction Date	Type of Owner
EVLO	Evelo Biosciences Inc	2022-05-27	10 percent owner
MCRB	Seres Therapeutics Inc	2022-07-05	10 percent owner
OMGAQ	Omega Therapeutics Inc	2023-02-27	10 percent owner

Flagship Pioneering Fund Vii General Partner Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Flagship Pioneering Fund Vii General Partner Llc Ownership Network

Ownership Network List of Flagship Pioneering Fund Vii General Partner Llc

No Data

Ownership Network Relation of Flagship Pioneering Fund Vii General Partner Llc

Flagship Pioneering Fund Vii General Partner Llc Owned Company Details

What does Evelo Biosciences Inc do?

Who are the key executives at Evelo Biosciences Inc?

Flagship Pioneering Fund Vii General Partner Llc is the 10 percent owner of Evelo Biosciences Inc. Other key executives at Evelo Biosciences Inc include Chief Medical Officer Duncan Mchale , Chief Financial Officer Marella Thorell , and See Remarks Mark Bodmer .

Evelo Biosciences Inc (EVLO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Evelo Biosciences Inc (EVLO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Evelo Biosciences Inc Insider Transactions

No Available Data

What does Seres Therapeutics Inc do?

Who are the key executives at Seres Therapeutics Inc?

Flagship Pioneering Fund Vii General Partner Llc is the 10 percent owner of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include Chief Scientific Officer Matthew R. Henn , CFO and EVP Eric D. Shaff , and See Remarks Teresa L. Young .

Seres Therapeutics Inc (MCRB) Insider Trades Summary

Over the past 18 months, Flagship Pioneering Fund Vii General Partner Llc made no insider transaction in Seres Therapeutics Inc (MCRB). Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 36,404 shares made by Teresa L. Young , a net sale of 40,701 shares made by Eric D. Shaff , and a net sale of 15,171 shares made by Thomas Desrosier .

In summary, during the past 3 months, insiders sold 439 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 439 shares. During the past 18 months, 7,137 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,137 shares.

Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Seres Therapeutics Inc Insider Transactions

No Available Data

What does Omega Therapeutics Inc do?

Who are the key executives at Omega Therapeutics Inc?

Flagship Pioneering Fund Vii General Partner Llc is the 10 percent owner of Omega Therapeutics Inc. Other key executives at Omega Therapeutics Inc include director & 10 percent owner Richard A Young , 10 percent owner Flagship Pioneering Fund Vii, L.p. , and 10 percent owner Flagship Pioneering Special Opportunities Fund Ii General Partner Llc .

Omega Therapeutics Inc (OMGAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Omega Therapeutics Inc (OMGAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Omega Therapeutics Inc (OMGAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Omega Therapeutics Inc (OMGAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Omega Therapeutics Inc Insider Transactions

No Available Data

Flagship Pioneering Fund Vii General Partner Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Flagship Pioneering Fund Vii General Partner Llc. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Flagship Pioneering Fund Vii General Partner Llc's mailing address is: Cambridge Ma 02142.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.